Nasdaq

Abbott's BinaxNOW COVID-19 Rapid Test Receives FDA Emergency Use Authorization for First Virtually Guided, At-Home Rapid Test Using eMed's Digital Health Platform

- First at-home, virtually guided service to bring rapid, reliable and affordable testing into the home where the result is delivered in minutes - Abbott and eMed™ expect to deliver and administer 30 ...
Pharmabiz

US FDA grants EUA for virtually guided at-home use of Abbott's BinaXNOW COVID-19 Ag Card rapid test for COVID-19 detection

Abbott announced that the US Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for virtually guided at-home use of its BinaxNOW COVID-19 Ag Card rapid test for detection ...
Medscape

FDA OKs Home Use of BinaxNOW 15-Minute COVID-19 Antigen Test

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. The BinaxNOW COVID-19 Ag Card (Abbott) rapid antigen test for SARS-CoV-2 can now be used at home ...
MobiHealthNews

Abbott scores EUA for at-home COVID-19 antigen testing kit

Abbott landed an emergency use authorization (EUA) for a new at-home coronavirus antigen test where users can perform the test on themselves via digital guidance and get results in 20 minutes. The ...
PharmiWeb

Abbott's BinaxNOW COVID-19 Rapid Test Receives FDA Emergency Use Authorization for First Virtually Guided, At-Home Rapid Test Using eMed's Digital Health Platform

ABBOTT PARK, Ill.,, Dec. 16, 2020 /PRNewswire/ -- Abbott (NYSE: ABT) announced today that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for virtually guided ...